Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 2,881-2,892 of 10,592
Drug study icon
CompletedNCT04030143

A study of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolarity type I

This study exists to better understand the safety of the medication Multiple-doses and how manageable it feels in practice. Researchers are trying to understand how people respond to the medication Multiple-doses in practice and what may need to be adjusted.

In United States
Bipolarity, SchizophreniaDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT00762268

A study of SAMe for Treatment-Resistant Depression in bipolarity

This study exists to see whether the medication SAMe can play a useful role in care. Researchers are trying to understand what the medication SAMe could change in day-to-day care and decision-making.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Mclean Hospital
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT03854409

A study of Single- and Multiple-doses of Aripiprazole in Adult Subjects With Schizophrenia or Bipolarity type I

This study exists to explore whether the medication Single could improve care and understanding. Researchers are trying to understand what the medication Single could change in day-to-day care and decision-making.

In United States
Bipolarity, SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Bipolarity, Schizophrenia
Drug study icon
CompletedNCT06229977

A study of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Depression in bipolarity

This study exists to explore whether this type of care could improve care and understanding. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT05593029

A study of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder

This study exists to explore whether a therapy or guided support program could improve care and understanding. Researchers are trying to understand what a therapy or guided support program could change in day-to-day care and decision-making.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression
Device study icon
Active Not RecruitingNCT05102864

A study of Two-Week Brain Stimulation for Teenagers With ADHD

This study is comparing Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex with Sham intermittent Theta Burst Stimulation for people with Adhd. Participants receive Intermittent Theta Burst Stimulation to the Left Dorsolateral Prefrontal Cortex or Sham intermittent Theta Burst Stimulation and complete study visits and assessments.

In United States
ADHDDeviceA study involving a tool, app, wearable, test, or medical device.From 12 Years to 18 Years
Countries
United States
Sponsor
Bradley Hospital
Condition
ADHD
Drug study icon
CompletedNCT06372210

A study to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

This study exists to explore whether a digital app or remote support tool could improve care and understanding. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.

Remote / online
Depression, Schizophrenia, ...DrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression, Schizophrenia, ...
Drug study icon
CompletedNCT07314333

A study to Assess How Centanafadine Interacts With Stimulants in the Body

This study is looking at whether a digital support tool can help people with Adhd. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.